0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Neurostimulation and Neuromodulation Device Market Research Report 2023
Published Date: March 2023
|
Report Code: QYRE-Auto-32N9342
Home | Market Reports | Health| Medical Devices & Equipment
Global Neurostimulation and Neuromodulation Device Market Insights and Forecast to 2028
BUY CHAPTERS

Global Neurostimulation and Neuromodulation Device Market Research Report 2023

Code: QYRE-Auto-32N9342
Report
March 2023
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Global Neurostimulation and Neuromodulation Device Market

The global Neurostimulation and Neuromodulation Device market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Neurostimulation and Neuromodulation Device is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Neurostimulation and Neuromodulation Device is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Neurostimulation and Neuromodulation Device include Axogen, Baxter, Boston Scientific, Livanova, Integra Lifesciences, Medtronic, Abbott Laboratories, Stryker and Polyganics, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Neurostimulation and Neuromodulation Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neurostimulation and Neuromodulation Device.
The Neurostimulation and Neuromodulation Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Neurostimulation and Neuromodulation Device market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neurostimulation and Neuromodulation Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

Key Segmentations

By Company

  • Axogen
  • Baxter
  • Boston Scientific
  • Livanova
  • Integra Lifesciences
  • Medtronic
  • Abbott Laboratories
  • Stryker
  • Polyganics
  • Nuvectra
  • Neuropace
  • Orthomed
  • Nevro

Segment by Type

  • Internal
  • External

Segment by Application

  • Hospitals and clinics
  • Ambulatory Surgery Center

Consumption by Region

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Australia
  • Taiwan
  • Indonesia
  • Thailand
  • Malaysia
  • Philippines
  • Vietnam
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Neurostimulation and Neuromodulation Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Neurostimulation and Neuromodulation Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

Scope of Global Neurostimulation and Neuromodulation Device Market Report

Report MetricDetails
Report NameGlobal Neurostimulation and Neuromodulation Device Market
Base Year2022
Forecasted years2023-2029
Forecast unitsUSD
Report coverageRevenue and volume forecast, company share, competitive landscape, growth factors and trends
Geographic regions coveredNorth America, Europe, Asia Pacific, Latin America, Middle East & Africa
1 Neurostimulation and Neuromodulation Device Market Overview
1.1 Product Overview and Scope of Neurostimulation and Neuromodulation Device
1.2 Neurostimulation and Neuromodulation Device Segment by Type
1.2.1 Global Neurostimulation and Neuromodulation Device Market Value Comparison by Type (2023-2029)
1.2.2 Internal
1.2.3 External
1.3 Neurostimulation and Neuromodulation Device Segment by Application
1.3.1 Global Neurostimulation and Neuromodulation Device Market Value by Application: (2023-2029)
1.3.2 Hospitals and clinics
1.3.3 Ambulatory Surgery Center
1.4 Global Neurostimulation and Neuromodulation Device Market Size Estimates and Forecasts
1.4.1 Global Neurostimulation and Neuromodulation Device Revenue 2018-2029
1.4.2 Global Neurostimulation and Neuromodulation Device Sales 2018-2029
1.4.3 Global Neurostimulation and Neuromodulation Device Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Neurostimulation and Neuromodulation Device Market Competition by Manufacturers
2.1 Global Neurostimulation and Neuromodulation Device Sales Market Share by Manufacturers (2018-2023)
2.2 Global Neurostimulation and Neuromodulation Device Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Neurostimulation and Neuromodulation Device Average Price by Manufacturers (2018-2023)
2.4 Global Neurostimulation and Neuromodulation Device Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Neurostimulation and Neuromodulation Device, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Neurostimulation and Neuromodulation Device, Product Type & Application
2.7 Neurostimulation and Neuromodulation Device Market Competitive Situation and Trends
2.7.1 Neurostimulation and Neuromodulation Device Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Neurostimulation and Neuromodulation Device Players Market Share by Revenue
2.7.3 Global Neurostimulation and Neuromodulation Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Neurostimulation and Neuromodulation Device Retrospective Market Scenario by Region
3.1 Global Neurostimulation and Neuromodulation Device Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Neurostimulation and Neuromodulation Device Global Neurostimulation and Neuromodulation Device Sales by Region: 2018-2029
3.2.1 Global Neurostimulation and Neuromodulation Device Sales by Region: 2018-2023
3.2.2 Global Neurostimulation and Neuromodulation Device Sales by Region: 2024-2029
3.3 Global Neurostimulation and Neuromodulation Device Global Neurostimulation and Neuromodulation Device Revenue by Region: 2018-2029
3.3.1 Global Neurostimulation and Neuromodulation Device Revenue by Region: 2018-2023
3.3.2 Global Neurostimulation and Neuromodulation Device Revenue by Region: 2024-2029
3.4 North America Neurostimulation and Neuromodulation Device Market Facts & Figures by Country
3.4.1 North America Neurostimulation and Neuromodulation Device Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Neurostimulation and Neuromodulation Device Sales by Country (2018-2029)
3.4.3 North America Neurostimulation and Neuromodulation Device Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Neurostimulation and Neuromodulation Device Market Facts & Figures by Country
3.5.1 Europe Neurostimulation and Neuromodulation Device Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Neurostimulation and Neuromodulation Device Sales by Country (2018-2029)
3.5.3 Europe Neurostimulation and Neuromodulation Device Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Neurostimulation and Neuromodulation Device Market Facts & Figures by Country
3.6.1 Asia Pacific Neurostimulation and Neuromodulation Device Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Neurostimulation and Neuromodulation Device Sales by Country (2018-2029)
3.6.3 Asia Pacific Neurostimulation and Neuromodulation Device Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Neurostimulation and Neuromodulation Device Market Facts & Figures by Country
3.7.1 Latin America Neurostimulation and Neuromodulation Device Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Neurostimulation and Neuromodulation Device Sales by Country (2018-2029)
3.7.3 Latin America Neurostimulation and Neuromodulation Device Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Neurostimulation and Neuromodulation Device Market Facts & Figures by Country
3.8.1 Middle East and Africa Neurostimulation and Neuromodulation Device Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Neurostimulation and Neuromodulation Device Sales by Country (2018-2029)
3.8.3 Middle East and Africa Neurostimulation and Neuromodulation Device Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Neurostimulation and Neuromodulation Device Sales by Type (2018-2029)
4.1.1 Global Neurostimulation and Neuromodulation Device Sales by Type (2018-2023)
4.1.2 Global Neurostimulation and Neuromodulation Device Sales by Type (2024-2029)
4.1.3 Global Neurostimulation and Neuromodulation Device Sales Market Share by Type (2018-2029)
4.2 Global Neurostimulation and Neuromodulation Device Revenue by Type (2018-2029)
4.2.1 Global Neurostimulation and Neuromodulation Device Revenue by Type (2018-2023)
4.2.2 Global Neurostimulation and Neuromodulation Device Revenue by Type (2024-2029)
4.2.3 Global Neurostimulation and Neuromodulation Device Revenue Market Share by Type (2018-2029)
4.3 Global Neurostimulation and Neuromodulation Device Price by Type (2018-2029)
5 Segment by Application
5.1 Global Neurostimulation and Neuromodulation Device Sales by Application (2018-2029)
5.1.1 Global Neurostimulation and Neuromodulation Device Sales by Application (2018-2023)
5.1.2 Global Neurostimulation and Neuromodulation Device Sales by Application (2024-2029)
5.1.3 Global Neurostimulation and Neuromodulation Device Sales Market Share by Application (2018-2029)
5.2 Global Neurostimulation and Neuromodulation Device Revenue by Application (2018-2029)
5.2.1 Global Neurostimulation and Neuromodulation Device Revenue by Application (2018-2023)
5.2.2 Global Neurostimulation and Neuromodulation Device Revenue by Application (2024-2029)
5.2.3 Global Neurostimulation and Neuromodulation Device Revenue Market Share by Application (2018-2029)
5.3 Global Neurostimulation and Neuromodulation Device Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Axogen
6.1.1 Axogen Corporation Information
6.1.2 Axogen Description and Business Overview
6.1.3 Axogen Neurostimulation and Neuromodulation Device Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Axogen Neurostimulation and Neuromodulation Device Product Portfolio
6.1.5 Axogen Recent Developments/Updates
6.2 Baxter
6.2.1 Baxter Corporation Information
6.2.2 Baxter Description and Business Overview
6.2.3 Baxter Neurostimulation and Neuromodulation Device Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Baxter Neurostimulation and Neuromodulation Device Product Portfolio
6.2.5 Baxter Recent Developments/Updates
6.3 Boston Scientific
6.3.1 Boston Scientific Corporation Information
6.3.2 Boston Scientific Description and Business Overview
6.3.3 Boston Scientific Neurostimulation and Neuromodulation Device Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Boston Scientific Neurostimulation and Neuromodulation Device Product Portfolio
6.3.5 Boston Scientific Recent Developments/Updates
6.4 Livanova
6.4.1 Livanova Corporation Information
6.4.2 Livanova Description and Business Overview
6.4.3 Livanova Neurostimulation and Neuromodulation Device Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Livanova Neurostimulation and Neuromodulation Device Product Portfolio
6.4.5 Livanova Recent Developments/Updates
6.5 Integra Lifesciences
6.5.1 Integra Lifesciences Corporation Information
6.5.2 Integra Lifesciences Description and Business Overview
6.5.3 Integra Lifesciences Neurostimulation and Neuromodulation Device Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Integra Lifesciences Neurostimulation and Neuromodulation Device Product Portfolio
6.5.5 Integra Lifesciences Recent Developments/Updates
6.6 Medtronic
6.6.1 Medtronic Corporation Information
6.6.2 Medtronic Description and Business Overview
6.6.3 Medtronic Neurostimulation and Neuromodulation Device Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Medtronic Neurostimulation and Neuromodulation Device Product Portfolio
6.6.5 Medtronic Recent Developments/Updates
6.7 Abbott Laboratories
6.6.1 Abbott Laboratories Corporation Information
6.6.2 Abbott Laboratories Description and Business Overview
6.6.3 Abbott Laboratories Neurostimulation and Neuromodulation Device Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Abbott Laboratories Neurostimulation and Neuromodulation Device Product Portfolio
6.7.5 Abbott Laboratories Recent Developments/Updates
6.8 Stryker
6.8.1 Stryker Corporation Information
6.8.2 Stryker Description and Business Overview
6.8.3 Stryker Neurostimulation and Neuromodulation Device Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Stryker Neurostimulation and Neuromodulation Device Product Portfolio
6.8.5 Stryker Recent Developments/Updates
6.9 Polyganics
6.9.1 Polyganics Corporation Information
6.9.2 Polyganics Description and Business Overview
6.9.3 Polyganics Neurostimulation and Neuromodulation Device Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Polyganics Neurostimulation and Neuromodulation Device Product Portfolio
6.9.5 Polyganics Recent Developments/Updates
6.10 Nuvectra
6.10.1 Nuvectra Corporation Information
6.10.2 Nuvectra Description and Business Overview
6.10.3 Nuvectra Neurostimulation and Neuromodulation Device Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Nuvectra Neurostimulation and Neuromodulation Device Product Portfolio
6.10.5 Nuvectra Recent Developments/Updates
6.11 Neuropace
6.11.1 Neuropace Corporation Information
6.11.2 Neuropace Neurostimulation and Neuromodulation Device Description and Business Overview
6.11.3 Neuropace Neurostimulation and Neuromodulation Device Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Neuropace Neurostimulation and Neuromodulation Device Product Portfolio
6.11.5 Neuropace Recent Developments/Updates
6.12 Orthomed
6.12.1 Orthomed Corporation Information
6.12.2 Orthomed Neurostimulation and Neuromodulation Device Description and Business Overview
6.12.3 Orthomed Neurostimulation and Neuromodulation Device Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Orthomed Neurostimulation and Neuromodulation Device Product Portfolio
6.12.5 Orthomed Recent Developments/Updates
6.13 Nevro
6.13.1 Nevro Corporation Information
6.13.2 Nevro Neurostimulation and Neuromodulation Device Description and Business Overview
6.13.3 Nevro Neurostimulation and Neuromodulation Device Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Nevro Neurostimulation and Neuromodulation Device Product Portfolio
6.13.5 Nevro Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Neurostimulation and Neuromodulation Device Industry Chain Analysis
7.2 Neurostimulation and Neuromodulation Device Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Neurostimulation and Neuromodulation Device Production Mode & Process
7.4 Neurostimulation and Neuromodulation Device Sales and Marketing
7.4.1 Neurostimulation and Neuromodulation Device Sales Channels
7.4.2 Neurostimulation and Neuromodulation Device Distributors
7.5 Neurostimulation and Neuromodulation Device Customers
8 Neurostimulation and Neuromodulation Device Market Dynamics
8.1 Neurostimulation and Neuromodulation Device Industry Trends
8.2 Neurostimulation and Neuromodulation Device Market Drivers
8.3 Neurostimulation and Neuromodulation Device Market Challenges
8.4 Neurostimulation and Neuromodulation Device Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Neurostimulation and Neuromodulation Device Market Value Comparison by Type (2023-2029) & (US$ Million)
    Table 2. Global Neurostimulation and Neuromodulation Device Market Value Comparison by Application (2023-2029) & (US$ Million)
    Table 3. Global Neurostimulation and Neuromodulation Device Market Competitive Situation by Manufacturers in 2022
    Table 4. Global Neurostimulation and Neuromodulation Device Sales (K Units) of Key Manufacturers (2018-2023)
    Table 5. Global Neurostimulation and Neuromodulation Device Sales Market Share by Manufacturers (2018-2023)
    Table 6. Global Neurostimulation and Neuromodulation Device Revenue (US$ Million) by Manufacturers (2018-2023)
    Table 7. Global Neurostimulation and Neuromodulation Device Revenue Share by Manufacturers (2018-2023)
    Table 8. Global Market Neurostimulation and Neuromodulation Device Average Price (USD/Unit) of Key Manufacturers (2018-2023)
    Table 9. Global Key Players of Neurostimulation and Neuromodulation Device, Industry Ranking, 2021 VS 2022 VS 2023
    Table 10. Global Key Manufacturers of Neurostimulation and Neuromodulation Device, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Neurostimulation and Neuromodulation Device, Product Type & Application
    Table 12. Global Key Manufacturers of Neurostimulation and Neuromodulation Device, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Neurostimulation and Neuromodulation Device by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurostimulation and Neuromodulation Device as of 2022)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Neurostimulation and Neuromodulation Device Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 17. Global Neurostimulation and Neuromodulation Device Sales by Region (2018-2023) & (K Units)
    Table 18. Global Neurostimulation and Neuromodulation Device Sales Market Share by Region (2018-2023)
    Table 19. Global Neurostimulation and Neuromodulation Device Sales by Region (2024-2029) & (K Units)
    Table 20. Global Neurostimulation and Neuromodulation Device Sales Market Share by Region (2024-2029)
    Table 21. Global Neurostimulation and Neuromodulation Device Revenue by Region (2018-2023) & (US$ Million)
    Table 22. Global Neurostimulation and Neuromodulation Device Revenue Market Share by Region (2018-2023)
    Table 23. Global Neurostimulation and Neuromodulation Device Revenue by Region (2024-2029) & (US$ Million)
    Table 24. Global Neurostimulation and Neuromodulation Device Revenue Market Share by Region (2024-2029)
    Table 25. North America Neurostimulation and Neuromodulation Device Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 26. North America Neurostimulation and Neuromodulation Device Sales by Country (2018-2023) & (K Units)
    Table 27. North America Neurostimulation and Neuromodulation Device Sales by Country (2024-2029) & (K Units)
    Table 28. North America Neurostimulation and Neuromodulation Device Revenue by Country (2018-2023) & (US$ Million)
    Table 29. North America Neurostimulation and Neuromodulation Device Revenue by Country (2024-2029) & (US$ Million)
    Table 30. Europe Neurostimulation and Neuromodulation Device Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 31. Europe Neurostimulation and Neuromodulation Device Sales by Country (2018-2023) & (K Units)
    Table 32. Europe Neurostimulation and Neuromodulation Device Sales by Country (2024-2029) & (K Units)
    Table 33. Europe Neurostimulation and Neuromodulation Device Revenue by Country (2018-2023) & (US$ Million)
    Table 34. Europe Neurostimulation and Neuromodulation Device Revenue by Country (2024-2029) & (US$ Million)
    Table 35. Asia Pacific Neurostimulation and Neuromodulation Device Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
    Table 36. Asia Pacific Neurostimulation and Neuromodulation Device Sales by Region (2018-2023) & (K Units)
    Table 37. Asia Pacific Neurostimulation and Neuromodulation Device Sales by Region (2024-2029) & (K Units)
    Table 38. Asia Pacific Neurostimulation and Neuromodulation Device Revenue by Region (2018-2023) & (US$ Million)
    Table 39. Asia Pacific Neurostimulation and Neuromodulation Device Revenue by Region (2024-2029) & (US$ Million)
    Table 40. Latin America Neurostimulation and Neuromodulation Device Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 41. Latin America Neurostimulation and Neuromodulation Device Sales by Country (2018-2023) & (K Units)
    Table 42. Latin America Neurostimulation and Neuromodulation Device Sales by Country (2024-2029) & (K Units)
    Table 43. Latin America Neurostimulation and Neuromodulation Device Revenue by Country (2018-2023) & (US$ Million)
    Table 44. Latin America Neurostimulation and Neuromodulation Device Revenue by Country (2024-2029) & (US$ Million)
    Table 45. Middle East & Africa Neurostimulation and Neuromodulation Device Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 46. Middle East & Africa Neurostimulation and Neuromodulation Device Sales by Country (2018-2023) & (K Units)
    Table 47. Middle East & Africa Neurostimulation and Neuromodulation Device Sales by Country (2024-2029) & (K Units)
    Table 48. Middle East & Africa Neurostimulation and Neuromodulation Device Revenue by Country (2018-2023) & (US$ Million)
    Table 49. Middle East & Africa Neurostimulation and Neuromodulation Device Revenue by Country (2024-2029) & (US$ Million)
    Table 50. Global Neurostimulation and Neuromodulation Device Sales (K Units) by Type (2018-2023)
    Table 51. Global Neurostimulation and Neuromodulation Device Sales (K Units) by Type (2024-2029)
    Table 52. Global Neurostimulation and Neuromodulation Device Sales Market Share by Type (2018-2023)
    Table 53. Global Neurostimulation and Neuromodulation Device Sales Market Share by Type (2024-2029)
    Table 54. Global Neurostimulation and Neuromodulation Device Revenue (US$ Million) by Type (2018-2023)
    Table 55. Global Neurostimulation and Neuromodulation Device Revenue (US$ Million) by Type (2024-2029)
    Table 56. Global Neurostimulation and Neuromodulation Device Revenue Market Share by Type (2018-2023)
    Table 57. Global Neurostimulation and Neuromodulation Device Revenue Market Share by Type (2024-2029)
    Table 58. Global Neurostimulation and Neuromodulation Device Price (USD/Unit) by Type (2018-2023)
    Table 59. Global Neurostimulation and Neuromodulation Device Price (USD/Unit) by Type (2024-2029)
    Table 60. Global Neurostimulation and Neuromodulation Device Sales (K Units) by Application (2018-2023)
    Table 61. Global Neurostimulation and Neuromodulation Device Sales (K Units) by Application (2024-2029)
    Table 62. Global Neurostimulation and Neuromodulation Device Sales Market Share by Application (2018-2023)
    Table 63. Global Neurostimulation and Neuromodulation Device Sales Market Share by Application (2024-2029)
    Table 64. Global Neurostimulation and Neuromodulation Device Revenue (US$ Million) by Application (2018-2023)
    Table 65. Global Neurostimulation and Neuromodulation Device Revenue (US$ Million) by Application (2024-2029)
    Table 66. Global Neurostimulation and Neuromodulation Device Revenue Market Share by Application (2018-2023)
    Table 67. Global Neurostimulation and Neuromodulation Device Revenue Market Share by Application (2024-2029)
    Table 68. Global Neurostimulation and Neuromodulation Device Price (USD/Unit) by Application (2018-2023)
    Table 69. Global Neurostimulation and Neuromodulation Device Price (USD/Unit) by Application (2024-2029)
    Table 70. Axogen Corporation Information
    Table 71. Axogen Description and Business Overview
    Table 72. Axogen Neurostimulation and Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 73. Axogen Neurostimulation and Neuromodulation Device Product
    Table 74. Axogen Recent Developments/Updates
    Table 75. Baxter Corporation Information
    Table 76. Baxter Description and Business Overview
    Table 77. Baxter Neurostimulation and Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 78. Baxter Neurostimulation and Neuromodulation Device Product
    Table 79. Baxter Recent Developments/Updates
    Table 80. Boston Scientific Corporation Information
    Table 81. Boston Scientific Description and Business Overview
    Table 82. Boston Scientific Neurostimulation and Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 83. Boston Scientific Neurostimulation and Neuromodulation Device Product
    Table 84. Boston Scientific Recent Developments/Updates
    Table 85. Livanova Corporation Information
    Table 86. Livanova Description and Business Overview
    Table 87. Livanova Neurostimulation and Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 88. Livanova Neurostimulation and Neuromodulation Device Product
    Table 89. Livanova Recent Developments/Updates
    Table 90. Integra Lifesciences Corporation Information
    Table 91. Integra Lifesciences Description and Business Overview
    Table 92. Integra Lifesciences Neurostimulation and Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 93. Integra Lifesciences Neurostimulation and Neuromodulation Device Product
    Table 94. Integra Lifesciences Recent Developments/Updates
    Table 95. Medtronic Corporation Information
    Table 96. Medtronic Description and Business Overview
    Table 97. Medtronic Neurostimulation and Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 98. Medtronic Neurostimulation and Neuromodulation Device Product
    Table 99. Medtronic Recent Developments/Updates
    Table 100. Abbott Laboratories Corporation Information
    Table 101. Abbott Laboratories Description and Business Overview
    Table 102. Abbott Laboratories Neurostimulation and Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 103. Abbott Laboratories Neurostimulation and Neuromodulation Device Product
    Table 104. Abbott Laboratories Recent Developments/Updates
    Table 105. Stryker Corporation Information
    Table 106. Stryker Description and Business Overview
    Table 107. Stryker Neurostimulation and Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 108. Stryker Neurostimulation and Neuromodulation Device Product
    Table 109. Stryker Recent Developments/Updates
    Table 110. Polyganics Corporation Information
    Table 111. Polyganics Description and Business Overview
    Table 112. Polyganics Neurostimulation and Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 113. Polyganics Neurostimulation and Neuromodulation Device Product
    Table 114. Polyganics Recent Developments/Updates
    Table 115. Nuvectra Corporation Information
    Table 116. Nuvectra Description and Business Overview
    Table 117. Nuvectra Neurostimulation and Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 118. Nuvectra Neurostimulation and Neuromodulation Device Product
    Table 119. Nuvectra Recent Developments/Updates
    Table 120. Neuropace Corporation Information
    Table 121. Neuropace Description and Business Overview
    Table 122. Neuropace Neurostimulation and Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 123. Neuropace Neurostimulation and Neuromodulation Device Product
    Table 124. Neuropace Recent Developments/Updates
    Table 125. Orthomed Corporation Information
    Table 126. Orthomed Description and Business Overview
    Table 127. Orthomed Neurostimulation and Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 128. Orthomed Neurostimulation and Neuromodulation Device Product
    Table 129. Orthomed Recent Developments/Updates
    Table 130. Nevro Corporation Information
    Table 131. Nevro Description and Business Overview
    Table 132. Nevro Neurostimulation and Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 133. Nevro Neurostimulation and Neuromodulation Device Product
    Table 134. Nevro Recent Developments/Updates
    Table 135. Key Raw Materials Lists
    Table 136. Raw Materials Key Suppliers Lists
    Table 137. Neurostimulation and Neuromodulation Device Distributors List
    Table 138. Neurostimulation and Neuromodulation Device Customers List
    Table 139. Neurostimulation and Neuromodulation Device Market Trends
    Table 140. Neurostimulation and Neuromodulation Device Market Drivers
    Table 141. Neurostimulation and Neuromodulation Device Market Challenges
    Table 142. Neurostimulation and Neuromodulation Device Market Restraints
    Table 143. Research Programs/Design for This Report
    Table 144. Key Data Information from Secondary Sources
    Table 145. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Neurostimulation and Neuromodulation Device
    Figure 2. Global Neurostimulation and Neuromodulation Device Market Value Comparison by Type (2023-2029) & (US$ Million)
    Figure 3. Global Neurostimulation and Neuromodulation Device Market Share by Type in 2022 & 2029
    Figure 4. Internal Product Picture
    Figure 5. External Product Picture
    Figure 6. Global Neurostimulation and Neuromodulation Device Market Value Comparison by Application (2023-2029) & (US$ Million)
    Figure 7. Global Neurostimulation and Neuromodulation Device Market Share by Application in 2022 & 2029
    Figure 8. Hospitals and clinics
    Figure 9. Ambulatory Surgery Center
    Figure 10. Global Neurostimulation and Neuromodulation Device Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 11. Global Neurostimulation and Neuromodulation Device Market Size (2018-2029) & (US$ Million)
    Figure 12. Global Neurostimulation and Neuromodulation Device Sales (2018-2029) & (K Units)
    Figure 13. Global Neurostimulation and Neuromodulation Device Average Price (USD/Unit) & (2018-2029)
    Figure 14. Neurostimulation and Neuromodulation Device Report Years Considered
    Figure 15. Neurostimulation and Neuromodulation Device Sales Share by Manufacturers in 2022
    Figure 16. Global Neurostimulation and Neuromodulation Device Revenue Share by Manufacturers in 2022
    Figure 17. The Global 5 and 10 Largest Neurostimulation and Neuromodulation Device Players: Market Share by Revenue in 2022
    Figure 18. Neurostimulation and Neuromodulation Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
    Figure 19. Global Neurostimulation and Neuromodulation Device Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Figure 20. North America Neurostimulation and Neuromodulation Device Sales Market Share by Country (2018-2029)
    Figure 21. North America Neurostimulation and Neuromodulation Device Revenue Market Share by Country (2018-2029)
    Figure 22. U.S. Neurostimulation and Neuromodulation Device Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 23. Canada Neurostimulation and Neuromodulation Device Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 24. Europe Neurostimulation and Neuromodulation Device Sales Market Share by Country (2018-2029)
    Figure 25. Europe Neurostimulation and Neuromodulation Device Revenue Market Share by Country (2018-2029)
    Figure 26. Germany Neurostimulation and Neuromodulation Device Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 27. France Neurostimulation and Neuromodulation Device Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 28. U.K. Neurostimulation and Neuromodulation Device Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 29. Italy Neurostimulation and Neuromodulation Device Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 30. Russia Neurostimulation and Neuromodulation Device Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 31. Asia Pacific Neurostimulation and Neuromodulation Device Sales Market Share by Region (2018-2029)
    Figure 32. Asia Pacific Neurostimulation and Neuromodulation Device Revenue Market Share by Region (2018-2029)
    Figure 33. China Neurostimulation and Neuromodulation Device Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 34. Japan Neurostimulation and Neuromodulation Device Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 35. South Korea Neurostimulation and Neuromodulation Device Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 36. India Neurostimulation and Neuromodulation Device Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 37. Australia Neurostimulation and Neuromodulation Device Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 38. Taiwan Neurostimulation and Neuromodulation Device Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 39. Indonesia Neurostimulation and Neuromodulation Device Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 40. Thailand Neurostimulation and Neuromodulation Device Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 41. Malaysia Neurostimulation and Neuromodulation Device Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 42. Philippines Neurostimulation and Neuromodulation Device Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 43. Latin America Neurostimulation and Neuromodulation Device Sales Market Share by Country (2018-2029)
    Figure 44. Latin America Neurostimulation and Neuromodulation Device Revenue Market Share by Country (2018-2029)
    Figure 45. Mexico Neurostimulation and Neuromodulation Device Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 46. Brazil Neurostimulation and Neuromodulation Device Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 47. Argentina Neurostimulation and Neuromodulation Device Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 48. Middle East & Africa Neurostimulation and Neuromodulation Device Sales Market Share by Country (2018-2029)
    Figure 49. Middle East & Africa Neurostimulation and Neuromodulation Device Revenue Market Share by Country (2018-2029)
    Figure 50. Turkey Neurostimulation and Neuromodulation Device Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 51. Saudi Arabia Neurostimulation and Neuromodulation Device Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 52. UAE Neurostimulation and Neuromodulation Device Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 53. Global Sales Market Share of Neurostimulation and Neuromodulation Device by Type (2018-2029)
    Figure 54. Global Revenue Market Share of Neurostimulation and Neuromodulation Device by Type (2018-2029)
    Figure 55. Global Neurostimulation and Neuromodulation Device Price (USD/Unit) by Type (2018-2029)
    Figure 56. Global Sales Market Share of Neurostimulation and Neuromodulation Device by Application (2018-2029)
    Figure 57. Global Revenue Market Share of Neurostimulation and Neuromodulation Device by Application (2018-2029)
    Figure 58. Global Neurostimulation and Neuromodulation Device Price (USD/Unit) by Application (2018-2029)
    Figure 59. Neurostimulation and Neuromodulation Device Value Chain
    Figure 60. Neurostimulation and Neuromodulation Device Production Process
    Figure 61. Channels of Distribution (Direct Vs Distribution)
    Figure 62. Distributors Profiles
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Prosthetic Biological Heart Valves Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-5I13093
Thu Jun 20 00:00:00 UTC 2024

Add to Cart

Global Sterilization Bag Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-11V11008
Thu Jun 20 00:00:00 UTC 2024

Add to Cart

Global Medical Hamper Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-20E11593
Thu Jun 20 00:00:00 UTC 2024

Add to Cart

Global Medical Examination Light Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-27F10740
Thu Jun 20 00:00:00 UTC 2024

Add to Cart